MedicalResearch.com Interview with:
Sean Ianchulev, MD MPH
Chief Medical Officer
VP of Medical Affairs and Business Development
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: Similar to MIGS stent technology for glaucoma, MiLOOP is a an application of micro-interventional technology for cataract surgery – allows the fragmentation of the lens with simple micro-interventional pen-like device which does not require complex, capital-intense phaco-emulsification…also it does not require vibrational energy
MedicalResearch.com: What should readers take away from your report?
MedicalResearch.com: What recommendations do you have for future research as a result of this study?
Response: Future studies will evaluate whether micro-interventional approaches for cataract surgery can replace phacoemulsification equipment altogether.
I am the founder and Chairman of the company.
MedicalResearch.com: Thank you for your contribution to the MedicalResearch.com community.
Note: Content is Not intended as medical advice. Please consult your health care provider regarding your specific medical condition and questions.